CIK 0001130598 · Non-accelerated filer<br>Smaller reporting company
Traws Pharma, Inc.
Sign in to watch- Ticker
- TRAW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 267-759-3680
- Business address
- 12 PENNS TRAIL, NEWTOWN, PA, 18940
- Former names
- Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Pauza Charles David Chief Science Officer Virology | Grant or award · Stock Option (right to purchase) | +503,227 | 503,227 | ||
| 2024-04-01 | CAUTREELS WERNER Chief Executive Officer | Grant or award | +200,000 | 200,000 | ||
| 2024-04-01 | Savchuk Nikolay Chief Operating Officer | Grant or award | +66,687 | 66,687 | ||
| 2024-04-01 | Savchuk Nikolay Chief Operating Officer | Grant or award | +67,550 | 134,187 | ||
| 2024-04-01 | Savchuk Nikolay Chief Operating Officer | Grant or award | +885,532 | 885,532 | ||
| 2024-04-01 | Savchuk Nikolay Chief Operating Officer | Grant or award | +1,645,100 | 1,645,100 | ||
| 2024-04-01 | Savchuk Nikolay Chief Operating Officer | Grant or award · Stock Option (right to purchase) | +3,802,890 | 3,802,890 | ||
| 2024-04-01 | Savchuk Nikolay Chief Operating Officer | Grant or award · Series C Preferred Stock | +194.62 | 194.62 | ||
| 2024-04-01 | Savchuk Nikolay Chief Operating Officer | Grant or award · Series C Preferred Stock | +2,584.37 | 2,584.37 | ||
| 2024-04-01 | Savchuk Nikolay Chief Operating Officer | Grant or award · Series C Preferred Stock | +4,801.11 | 4,801.11 | ||
| 2024-04-01 | Dukes Iain D. Executive Chairman | Grant or award | +66,687 | 66,687 | ||
| 2024-04-01 | Dukes Iain D. Executive Chairman | Grant or award | +67,550 | 134,187 | ||
| 2024-04-01 | Dukes Iain D. Executive Chairman | Grant or award | +1,645,100 | 1,645,100 | ||
| 2024-04-01 | Dukes Iain D. Executive Chairman | Grant or award · Stock Option (right to purchase) | +3,802,890 | 3,802,890 | ||
| 2024-04-01 | Dukes Iain D. Executive Chairman | Grant or award · Series C Preferred Stock | +194.62 | 194.62 | ||
| 2024-04-01 | Dukes Iain D. Executive Chairman | Grant or award · Series C Preferred Stock | +4,801.11 | 4,801.11 | ||
| 2024-03-14 | Guerin Mark Patrick CFO AND COO | Shares withheld for taxes | −2,591 | $0.90 | $2K | 35,976 |
| 2024-03-14 | Fruchtman Steven M PRESIDENT, CHIEF EXECUTIVE OFF | Shares withheld for taxes | −8,727 | $0.90 | $8K | 74,792 |
| 2024-03-13 | Guerin Mark Patrick CFO AND COO | Option exercise | +8,666 | 38,567 | ||
| 2024-03-13 | Guerin Mark Patrick CFO AND COO | Option exercise · Restricted Stock Units | −8,666 | 17,334 |
Page 5 of 9 · 170 trades